Subjects with MnSOD Val/Ala+Ala/Ala polymorphisms also showed higher CAD risk, although less significant, in those with two-vessel disease (OR = 1.92, 95% CI = 1.02-3.06). This evidence concerns the gene SOD2 and coronary artery disorder.